MedTrace Logo

Treatment of Severe Hypertension With ICG Directed Therapy

NCT04748107 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-06-13

No results posted yet for this study

Summary

The purpose of the study is to compare the usefulness of Impedence Cardiography (ICG) directed therapy in treating severe range hypertension in pregnant women at term.

Conditions

  • Hypertension in Pregnancy

Interventions

DIAGNOSTIC_TEST

Impendence Cardiography

ICG is a noninvasive method of determining the amount of blood flow using the Non-Invasive Cardiac System - Cardiac Surveyor (NICaS) system, which provides an assessment of the cardiovascular system, respiratory system, and fluid retention.

Sponsors & Collaborators

  • Marshall University

    lead OTHER

Principal Investigators

  • Jesse Cottrell, MD · Marshall University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-25
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04748107 on ClinicalTrials.gov